2. Signaling Pathways
  3. Others
  4. Others

Others

 
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-156641
    Sontigidomide
    		98.62%
    Sontigidomide (Compound 5) is an antineoplastic compound. Sontigidomide inhibits MOLM-13 cell proliferation more than 80% at 1 μM (3 days).
    Sontigidomide
  • HY-162448
    SerBut
    		99.92%
    SerBut is a serine conjugated butyrate prodrug with oral activity. SerBut has anti-inflammatory activity.
    SerBut
  • HY-159681
    AASS-IN-1
    		98.40%
    AASS-IN-1 (Compound S-105) is an AASS (2-aminoadipic semialdehyde synthase) inhibitor with an IC50 value of 142 μM. AASS-IN-1 inhibits AASS activity by binding to the LOR domain of AASS. AASS-IN-1 holds potential for research in the field of hyperlysinemia.
    AASS-IN-1
  • HY-108751
    Aripiprazole Lauroxil
    		99.70%
    Aripiprazole lauroxil, an N-acyloxymethyl proagent of Aripiprazole (HY-14546), is a Long-acting injectable (LAI) typical antipsychotic for schizophrenia and a ligand of dopamine receptor D2R/D4R. Aripiprazole lauroxil is cleaved by body’s enzyme esterase to N-hydroxymethyl aripiprazole (plus lauric acid) and then to aripiprazole (plus formaldehyde), no toxicity.
    Aripiprazole Lauroxil
  • HY-33009
    AS057278
    		Inhibitor 99.76%
    AS057278 is a potent, selective, orally active and blood-brain barrier (BBB) penetrant non-peptidic D-amino acid oxidase (DAAO) inhibitor with an IC50 value of 0.91 μM and EC50 of 2.2-3.95 μM. AS057278 can normalize phencyclidine (PCP)-induced prepulse inhibition in mice. AS057278 can be used for researching schizophrenia.
    AS057278
  • HY-139059
    ERD03
    		Inhibitor
    ERD03 is a potent disruptor of the EXOSC3-RNA interaction, with a Kd of 17±7 μM . ERD03 induces PCH1B-like phenotype in zebrafish embryo and can be used for neurological disorder disease research.
    ERD03
  • HY-173527
    PSSI-51
    		Inhibitor 99.75%
    PSSI-51 is an orally active, peripherally selective inhibitor of succinyl-CoA:3-ketoacid-CoA transferase (SCOT). PSSI-51 inhibits SCOT activity in peripheral tissues (such as muscle and kidney) but does not affect SCOT activity in brain tissue. PSSI-51 reduces ketone body oxidation by inhibiting SCOT, thereby improving obesity-related hyperglycemia. PSSI-51 can be used in the study of type 2 diabetes (T2D) and has the potential to improve obesity-related metabolic disorders.
    PSSI-51
  • HY-135158
    Prolylvaline
    		99.53%
    Prolylvaline (Pro-Val) is a proline-valine dipeptide that can be used to bind fluorescein isothiocyanate (FITC). Prolylvaline has specific imprinting effects in Tetrahymena, inducing negative imprinting. Using protozoan organisms, proline dipeptides containing different partner amino acids can be distinguished from dipeptides with opposite amino acid positions.
    Prolylvaline
  • HY-126112
    Mephenoxalone
    		98.57%
    Mephenoxalone is a muscle relaxant with anti-anxiety activity. Mephenoxalone has neuropharmacologic activity in vivo. Mephenoxalone inhibits neuron transmission and can relax skeletal muscles by inhibiting the reflex arc.
    Mephenoxalone
  • HY-143539
    YQ456
    		99.84%
    YQ456 is a novel small molecule inhibitor of myoferlin that showed high binding affinity to myoferlin with a KD of 37 nM and excellent anti-invasion capability with an IC50 of 110 nM.
    YQ456
  • HY-W031510
    3,6-Dihydroxyxanthone
    		99.55%
    3,6-Dihydroxyxanthone (compound 3) is a xanthone derivatives. 3,6-Dihydroxyxanthone (compound 3) has anticancer activity. 3,6-Dihydroxyxanthone (compound 3) can be used for cancer research.
    3,6-Dihydroxyxanthone
  • HY-161904
    CDYL-IN-1
    		Inhibitor 99.80%
    CDYL-IN-1 (compound D03) is a CDYL inhibitor, with a KD of 0.5 μM. CDYL-IN-1 can be used in the research of acute kidney injury.
    CDYL-IN-1
  • HY-16395
    PG-11047
    		98.0%
    PG-11047 (CGC-11047) is a polyamine analogue. PG-11047 can be used for the research of breast cancer.
    PG-11047
  • HY-P991206
    Human IgG2 lambda, Isotype Control
    		98.85%
    Human IgG2 lambda, Isotype Control, a human monoclonal antibody, is an isotype control for human IgG2λ antibody.
    Human IgG2 lambda, Isotype Control
  • HY-108315
    6-Aminochrysene
    		99.71%
    6-Aminochrysene (6-Aminochrysene) is an aromatic amine used as a chemotherapeutic agent in the treatment of splenomegaly, myeloid leukemia, and breast cancer. 6-Aminochrysene is activated by CYP450 in rat liver.
    6-Aminochrysene
  • HY-W701069
    Isomyosmine
    Isomyosmine is a nitrate reductase inhibitor. Isomyosmine is a nicotine related alkaloid present in solanecea plants containing nicotine. Isomyosmine can be used for research of inflammation and age-related disorders
    Isomyosmine
  • HY-103001
    HMN-154
    HMN-154 is a novel benzenesulfonamide anticancer compound; inhibits KB and colon38 cells with IC50 values of 0.0026 and 0.003 μg/mL, respectively.
    HMN-154
  • HY-122066
    NSC47924
    NSC47924 is a laminin receptor (LR) inhibitor. NSC47924 affects 37/67 kDa LR cell surface localization and interaction with the cellular prion protein. NSC47924 can be used for testing prion diseases.
    NSC47924
  • HY-100303
    FR194738 free base
    		Inhibitor 99.84%
    FR194738 free base is a squalene epoxidase inhibitor. FR194738 inhibits squalene epoxidase activity in HepG2 cell homogenates with an IC50 of 9.8 nM.
    FR194738 free base
  • HY-157739
    1,2-Dioleoyl-3-arachidoylglycerol
    		99.0%
    1,2-Dioleoyl-3-arachidoylglycerol (AOO) is a triacylglycerol that can be isolated from soybean oil.
    1,2-Dioleoyl-3-arachidoylglycerol
Cat. No. Product Name / Synonyms Application Reactivity